A new study has found that an oral medicine called hydroxyuria can safely and effectively treat children with sickle cell disease. The research was published on 17 April in the Medical Journal Blood Advanced. The study showed that children who regularly took hydroxyuria had a low emergency room visit and they spent less time in the hospital than those who did not take medicines.

Dr. “Hydroxyuria is the most effective drug that we have for sickle cell disease, and this study shows that it keeps helping children over time,” Paul George, prominent researcher and a pediatrician bloodathist at Mori University in Atlanta, and shows that it keeps helping children over time. “

Sickle cell disease is a severe blood disorder that affects how red blood cells work. Instead of being round and smooth, red blood cells in people with the disease become sickle size and sticky. These cells can block blood flow, causing pain, infection and damage to organs. In the US, around 100,000 people live with sickle cell disease. It affects mostly black and Hispanic children.

Hydroxyurea is a bar-din tablet that helps red blood cells to stay healthy. It reduces the number of painful episodes and reduces the requirement of blood transfusion. The drug can also improve anemia and prevent clots in the lungs.

The US government recommends giving hydroxyuria to children with severe sickle cell disease starting from the age of 9 to 12 months. Although hydroxyuria was first used as chemotherapy medicine, it has been used for many years to treat sickle cell disease. Nevertheless, some families worry about long -term security, especially in children.

Another researcher of the study, Dr. Wilber Lam said, “Hydroxuria has always raised some safety concerns due to its history as chemotherapy. But this study should help families feel more confident that it is safe and helps children with sickle cells.”

More than 2,100 children were accompanied by sickle cell disease in the study, which were treated at least three times between 2010 and 2021 at Children’s Hospital in Atlanta. About 58 percent of the children took hydroxyuria, in which he had to live on medicine for about five years.

The results showed that the children who regularly took hydroxyuria were better their health results. He used to visit the hospital less often and was admitted to small stay, even researchers noticed how serious their condition was and he followed his treatment.

Dr. George said, “Hydroxuria’s benefits were clear, but we also saw that children who did not take it regularly did not get the same improvement. It shows how important it is to live with medicine.”

This study suggests that hydroxyuria is a safe and accessory treatment for children with sickle cell disease. This can bring a major change in their health and quality of life, especially when it is taken as determined.

Now get the latest news with health and braking news and top headlines worldwide.